| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |